XML 28 R7.htm IDEA: XBRL DOCUMENT v3.4.0.3
CONSOLIDATED STATEMENTS OF CASH FLOWS
¥ in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2015
USD ($)
Dec. 31, 2015
CNY (¥)
Dec. 31, 2014
CNY (¥)
Dec. 31, 2013
CNY (¥)
Cash flows from operating activities        
Net income/(loss) $ 7,084 ¥ 45,888 ¥ (16,701) ¥ 27,845
Adjustments to reconcile net income/(loss) to net cash provided by operating activities        
Depreciation of property and equipment 1,339 8,674 4,035 1,788
Amortization of intangible assets 10,663 69,075 ¥ 6,071 ¥ 1,990
Impairment of intangible assets 1,260 8,162
Impairment of prepaid minimum guarantee 2,200 14,385
Allowance for doubtful accounts $ 752 ¥ 4,870
Loss on disposals of property and equipment ¥ 208
Share-based compensation $ 16,030 ¥ 103,839 ¥ 185,750 ¥ 329
Impairment loss on cost method investments 3,029
Share of loss from equity method investments $ 401 ¥ 2,597 ¥ 697 ¥ 170
Fair value change of preferred share warrant liability 514
Deferred income taxes, net $ 5,010 ¥ 32,454 ¥ 28,267 (1,262)
Foreign exchange (loss)/gain and others 2,199 14,243 1,046 (266)
Changes in operating assets and liabilities, net of effect of acquisitions        
Accounts receivable (22,940) (148,599) (127,641) (71,848)
Amounts due from related parties 861 5,575 (16,221) (26)
Prepayments and other assets (25,337) (164,132) (184,136) (7,169)
Accounts payable 631 4,087 76,199 78,211
Accruals and other liabilities 2,568 16,632 20,196 ¥ 18,875
Deferred revenue 4,328 28,033 ¥ 41,411
Amounts due to related parties 2,158 13,977 ¥ 1,095
Income tax payable 4,810 31,160 ¥ (1,458) 7,239
Net cash provided by operating activities 14,017 90,920 20,544 57,693
Cash flows from investing activities        
Purchase of property and equipment (1,403) (9,089) (11,252) (8,473)
Cash paid for equity investments (15,373) (99,585) (19,369) ¥ (1,500)
Cash paid for Investment in available-for-sale securities (4,391) (28,442) ¥ (19,852)
Cash paid for business acquisition, net of cash acquired (3,074) (19,917)
Investment in short-term time deposits 617 4,000 ¥ (4,000)
Purchase of intangible assets $ (57,515) ¥ (372,570) ¥ (124,140) ¥ (2,520)
Repayment from a related party 5,687
Net cash used in investing activities $ (81,139) ¥ (525,603) ¥ (178,613) ¥ (6,806)
Cash flows from financing activities        
Proceeds from borrowings 16,981 110,000 ¥ 20,000
Repayments of borrowings (3,087) (20,000)
Governments grants received $ 1,684 ¥ 10,909
Proceeds from initial public offering (net of underwriters' commissions of US$9,962,000) ¥ 918,039
Payments of offering costs related to initial public offering $ (953) ¥ (6,173) ¥ (24,133)
Repurchase of ordinary shares $ (1,425) ¥ (9,235) ¥ (33,839)
Proceeds from issuance of preferred shares 134,350
Preferred shares issuance costs (6,961)
Proceeds from exercise of preferred share warrants 24,648
Payments for repurchase of preferred shares occurred in 2013 $ (1,340) ¥ (8,683) (17,672)
Proceeds from capital contribution from non-controlling interest ¥ 236
Proceeds from share options exercised $ 104 ¥ 674
Net cash provided by financing activities 11,964 77,492 ¥ 913,906 ¥ 100,762
Net increase/(decrease) in cash and cash equivalents (55,141) (357,191) 755,837 151,649
Cash and cash equivalents at beginning of the year 143,541 929,829 179,658 31,365
Effect of exchange (loss)/gain on cash and cash equivalents 3,346 21,674 (5,666) (3,356)
Cash and cash equivalents at end of the year $ 91,746 ¥ 594,312 929,829 179,658
Supplemental disclosure of non-cash investing and financing activities        
Accretion to convertible redeemable preferred shares redemption value ¥ 1,054,890 262,782
Repurchase of series A convertible redeemable preferred shares in form of payables ¥ 8,683
Acquisition of intangible assets in form of payables and not yet paid $ 2,643 ¥ 17,124 ¥ 20,229
Acquisition of equity investments in form of payables and not yet paid $ 2,533 ¥ 16,409 10,000
Conversion of preferred shares to ordinary shares 1,536,175
Initial public offering related cost in form of other payables and not yet paid ¥ 6,173
Unrealized gain on available-for-sale securities $ 5,515 ¥ 35,722